321 related articles for article (PubMed ID: 25423557)
1. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
3. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY
Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
[TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
6. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
9. Can long-term follow-up strategies be determined using a nomogram-based prediction model of malignancy among intraductal papillary mucinous neoplasms of the pancreas?
Hijioka S; Shimizu Y; Mizuno N; Hara K; Imaoka H; Mekky MA; Bhatia V; Nagashio Y; Hasegawa T; Shinagawa A; Sekine M; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
Pancreas; 2014 Apr; 43(3):367-72. PubMed ID: 24622065
[TBL] [Abstract][Full Text] [Related]
10. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model.
Casadei R; Ricci C; Ingaldi C; Cornacchia A; Migliori M; Di Marco M; Pagano N; Serra C; Alberici L; Minni F
Updates Surg; 2021 Apr; 73(2):429-438. PubMed ID: 33620642
[TBL] [Abstract][Full Text] [Related]
11. Should all branch-duct intraductal papillary mucinous neoplasms be resected?
Plichta JK; Ban K; Fridirici Z; Godambe AS; Yong S; Pappas S; Abood GJ; Aranha GV
Am J Surg; 2015 Mar; 209(3):478-82. PubMed ID: 25605032
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic juice cytology in IPMN of the pancreas.
Yamaguchi K; Nakamura M; Shirahane K; Kawamoto M; Konomi H; Ohta M; Tanaka M
Pancreatology; 2005; 5(4-5):416-21; discussion 421. PubMed ID: 15985766
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
15. A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm.
Shimizu Y; Kanemitsu Y; Sano T; Senda Y; Mizuno N; Yamao K
World J Surg; 2010 Dec; 34(12):2932-8. PubMed ID: 20845037
[TBL] [Abstract][Full Text] [Related]
16. Predicting malignant intraductal papillary mucinous neoplasm: a single-center review.
Cone MM; Rea JD; Diggs BS; Douthit MA; Billingsley KG; Sheppard BC
Am J Surg; 2011 May; 201(5):575-9. PubMed ID: 21545902
[TBL] [Abstract][Full Text] [Related]
17. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
18. New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm.
Shimizu Y; Hijioka S; Hirono S; Kin T; Ohtsuka T; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Matsuo K; Yanagisawa A; Yamaue H; Sugiyama M; Okazaki K
Ann Surg; 2020 Jul; 272(1):155-162. PubMed ID: 30499803
[TBL] [Abstract][Full Text] [Related]
19. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
20. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
Tanaka M
Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
